z-logo
open-access-imgOpen Access
Pharmaceutical proteins produced in plant bioreactor in recent years
Author(s) -
Zhengquan He,
Xiaochun Du,
Wei Yao,
Jianwu Dai
Publication year - 2008
Publication title -
african journal of biotechnology
Language(s) - English
DOI - 10.5897/ajb08.080
Plant bioreactor, also called molecular farming, has enormous potential to produce recombinant proteins infinitely. Products expressed in plants have natural physico-chemical properties and bioactivities. Plant bioreactor could be a safe, economic and convenient production system, and can been widely applied in industries and agricultures, especially in the life science and pharmaceutical industry. The application of transgenic plant in the production of vaccines, antibodies and pharmaceutical proteins has become a hot point in the plant genetic engineering in recent years. However, there are some limiting factors of application such as yield, downstream processing and so on. Here we review and discuss the advantages and research progress for the pharmaceutical plant bioreactors in recent three years, focusing on the existing problems and new strategies in this area.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom